A series of luminescent multinuclear platinum(II) alkynyl complexes containing triethynylbenzene or 1,4-bis(3,5-diethynylphenyl)buta-1,3-diyne as cores has been successfully synthesized and characterized. The electronic absorption, emission, nanosecond transient absorption and electrochemical properties of these complexes have been reported. These complexes show long-lived emissions in degassed benzene solution and in alcoholic glass at 77 K. Moreover, they are found to exhibit two-photon absorption (2PA) and two-photon induced luminescence (TPIL) properties, and their two-photon absorption cross-sections have been determined to be 6-191 GM upon excitation at 720 nm. Through a systematic comparison, it has been found that tetra- and hexanuclear platinum(II) complexes show better 2PA and TPIL properties than their di- and trinuclear counterparts.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c1dt10784d | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
What happened to BBR3464 and where to from here for multinuclear platinum-based anticancer drugs?
Dalton Trans
December 2024
School of Natural Sciences, Faculty of Science and Engineering, Macquarie University, NSW, 2109, Australia.
The development of the trinuclear platinum(II) complex BBR3464 (also known as triplatin) in the late 1990s was meant to be a revolution in the field of platinum chemotherapy. What made it remarkable was that it defied many of the known structure-activity rules for platinums; it is cationic, has a single labile leaving group on each terminal platinum, and it binds DNA in ways different to mononuclear platinum drugs, like cisplatin and oxaliplatin. The flexible, long-range adducts the drug forms with DNA means that it showed activity in cancers not typically sensitive to platinums, and more importantly, BBR3464 demonstrated an ability to overcome acquired resistance to platinum drugs.
View Article and Find Full Text PDFA Surface-Active Pt(II) Bis-N-Heterocyclic Carbene (NHC) Complex for Interface-Enhanced Supported Ionic Liquid Phase (SILP) Catalysis.
Chemistry
January 2025
Department of Chemistry and Pharmacy, Inorganic Chemistry, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Egerlandstraße 1, 91058, Erlangen, Germany.
We present the preparation and investigation of a fluorine-free surface-active bis-N-heterocyclic carbene (NHC) platinum(II) complex - trans-[Pt(mPEGCIm)Cl] - for interface-enhanced supported ionic liquid phase (SILP) catalysis within a group of (mPEG)-substituted ionic liquids (ILs) ([(mPEG)Im][A] ILs). The complex was characterized by means of single-crystal X-ray diffraction (scXRD) analysis and multinuclear (H, C, Pt) NMR spectroscopy, indicating the presence of two almost equimolar syn-anti-rotamers of the square-planar complex in solution. Angle-resolved X-ray photoelectron spectroscopy (ARXPS) revealed pronounced interface-accumulation of trans-[Pt(mPEGCIm)Cl] in IL solutions of [(mPEG)Im][A] (A=I and PF ).
View Article and Find Full Text PDFNot the usual suspect - an unexpected organometallic product during the synthesis of cytotoxic platinum(II) complexes.
Dalton Trans
November 2023
University of Vienna, Faculty of Chemistry, Department of Inorganic Chemistry, Waehringer Strasse 42, 1090 Vienna, Austria.
The reaction of (1,2)-(cyclohexane-1,2-diamine)dichloridoplatinum(II) with maleic acid unexpectedly resulted in the formation of an organometallic platinum(II) complex featuring a ,-coordinating ligand. Additionally, a small series of close derivatives with increasing lipophilicity was synthesized. All complexes were fully characterized by multinuclear one- and two-dimensional (H, C, N, and Pt) NMR spectroscopy, high resolution mass spectrometry, and in one case by X-ray diffraction.
View Article and Find Full Text PDFMultifunctional Pt(iv) prodrug candidates featuring the carboplatin core and deferoxamine.
Dalton Trans
June 2021
Institute of Inorganic Chemistry, University of Vienna, Waehringer Str. 42, 1090 Vienna, Austria.
The synergistic combination of the anticancer drug carboplatin and the iron chelator deferoxamine (DFO) served as a foundation for the development of novel multifunctional prodrugs. Hence, five platinum(iv) complexes, featuring the equatorial coordination sphere of carboplatin, and one or two DFO units incorporated at axial positions, were synthesized and characterized using ESI-HRMS, multinuclear (H, C, N, Pt) NMR spectroscopy and elemental analysis. Analytical studies demonstrated that the chelating properties of the DFO moiety were not compromised after coupling to the platinum(iv) core.
View Article and Find Full Text PDFSynthesis and Evaluation of the Cytotoxic Activity of Water-Soluble Cationic Organometallic Complexes of the Type [Pt(η-CHOMe)(L)(Phen)] (L = NH, DMSO; Phen = 1,10-Phenanthroline).
Pharmaceutics
April 2021
Dipartimento di Scienze e Tecnologie Biologiche ed Ambientali, Università del Salento, Prov.le Lecce-Monteroni, Centro Ecotekne, 73100 Lecce, Italy.
Starting from the [PtCl(η-CHOMe)(phen)] (phen = 1,10-phenanthroline, ) platinum(II) precursor, we synthesized and characterized by multinuclear NMR new [Pt(η-CHOMe)(L)(phen)] (L = NH, ; DMSO, ) complexes. These organometallic species, potentially able to interact with cell membrane organic cation transporters (OCT), violating some of the classical rules for antitumor activity of cisplatin analogues, were evaluated for their cytotoxicity. Interestingly, despite both complexes and resulting in greater cell uptake than cisplatin in selected tumor cell lines, only showed comparable or higher antitumor activity.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!